About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Alzheimer's Disease Clinical Trials in Phoenix | 240 Studies

Clinical Trials Alzheimer's DiseasePhoenix

Alzheimer's Disease Clinical Trials in Phoenix

Find 240 clinical trials for alzheimer's disease near Phoenix, Arizona. Connect with research centers in your area.

All Alzheimer's Disease trials nationwide All trials in Phoenix

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 61-80 of 240 trials

UnknownArizona Alzheimer's Disease Research Center (ADRC)The Arizona Alzheimer's Disease Research Center (ADRC) is the National Institute on Aging's (NIA's) first statewide AD Center (ADC), the only ADC in the Southwestern United…NCT05405075·Phoenix, Arizona and 4 others CompletedADNI: Alzheimer's Disease Neuroimaging InitiativeThe purpose of this study is to examine how brain imaging technology can be used with other tests to measure the progression of mild cognitive impairment (MCI) and early…NCT00106899·Birmingham, Alabama and 58 others

Alzheimer's Disease Trials in Other Cities

New York Los Angeles Chicago Houston Philadelphia San Antonio

Data from ClinicalTrials.govTerms

TerminatedA Study to Verify the Clinical Benefit of Aducanumab in Participants With Early Alzheimer's DiseaseThe primary objective of this study is to verify the clinical benefit of monthly doses of aducanumab in slowing cognitive and functional impairment as measured by changes in the…NCT05310071·Gilbert, Arizona and 264 others

CompletedA Study to Evaluate Safety, Tolerability, and Efficacy of Lecanemab in Subjects With Early Alzheimer's DiseaseThis is a multinational, multicenter, double-blind, placebo-controlled, parallel-group study using a Bayesian design with response adaptive randomization across placebo or 5…NCT01767311·Birmingham, Alabama and 168 others

TerminatedA Study of CNP520 Versus Placebo in Participants at Risk for the Onset of Clinical Symptoms of Alzheimer's DiseaseThe purpose of this study is to determine the effects of CNP520 on cognition, global clinical status, and underlying AD pathology, as well as the safety of CNP520, in people at…NCT03131453·Phoenix, Arizona and 193 others

TerminatedAn Efficacy and Safety Study of Lanabecestat (LY3314814) in Early Alzheimer's DiseaseThe purpose of this study is to assess the efficacy and safety of lanabecestat compared with placebo administered for 104 weeks in the treatment of early Alzheimer´s disease.NCT02245737·Phoenix, Arizona and 253 others

TerminatedPhase 3 IGIV, 10% in Alzheimer´s DiseaseThe purpose of this study is to provide evidence of efficacy and safety to support the development of IGIV, 10% as a treatment option for patients with mild to moderate…NCT01524887·Birmingham, Alabama and 68 others

RecruitingA Clinical Trial to Learn About the Effects of VHB937 in People With Early Alzheimer's DiseaseThis is a multicentre, randomized, double-blind, placebo-controlled, parallel group Phase II study to evaluate the efficacy and safety of VHB937 in participants with early AD…NCT07094516·Phoenix, Arizona and 73 others

TerminatedStudy Evaluating The Efficacy And Safety Of Bapineuzumab In Alzheimer Disease PatientsThis is a study to evaluate the efficacy and safety of multiple doses of bapineuzumab in patients with mild to moderate Alzheimer Disease.NCT00667810·Birmingham, Alabama and 345 others

RecruitingAlzheimer's Prevention Registry: A Program to Accelerate Enrollment Into StudiesThe Alzheimer's Prevention Registry (www.endALZnow.org) will collect contact and demographic information on individuals.NCT02022943·Phoenix, Arizona

UnknownEvaluation of 3APS in Patients With Mild to Moderate Alzheimer's DiseaseThe purpose of this Phase III study is to evaluate the efficacy and safety of 3APS compared to placebo (inactive substance pill) in patients with mild to moderate Alzheimer's…NCT00088673·Peoria, Arizona and 66 others

RecruitingStudy of LHP588 in Subjects With P. Gingivalis-Positive Alzheimer's DiseaseThis study is to test LHP588 in persons who have mild to moderate Alzheimer's disease (AD) who have shown progressive mental decline in the last year and who have P. gingivalis…NCT06847321·Phoenix, Arizona and 38 others

CompletedClinical Evaluation of Flortaucipir F 18This study is designed to expand the database of flortaucipir F 18 safety and tau binding as measured by PET imaging and to provide standardized conditions for flortaucipir PET…NCT02278367·Phoenix, Arizona and 4 others

CompletedCaring Relationships Expression StudyThis study will examine a heart rate variability biofeedback (HRVB) intervention versus a music listening control (MLC) for 30 family caregivers (FCGs) of Alzheimer's disease (AD)…NCT05627687·Phoenix, Arizona

Active not recruitingA Study of JNJ-64042056 in Participants With Preclinical Alzheimer's DiseaseThe purpose of this study is to assess whether JNJ-64042056 affects the spread and build up of tau (a protein in brain) when compared with placebo, using brain scan (tau PET) to…NCT06544616·Phoenix, Arizona and 89 others

CompletedELND005 in Patients With Mild to Moderate Alzheimer's DiseaseThe purpose of this study is to evaluate the dose-related safety and efficacy of multiple oral dosages of ELND005 as treatment for Alzheimer's disease (AD).NCT00568776·Phoenix, Arizona and 61 others

Completed18F-AV-1451 Autopsy StudyThis study is designed to test the relationship between ante-mortem flortaucipir Positron Emission Tomography (PET) imaging and tau neurofibrillary pathology associated with…NCT02516046·Phoenix, Arizona and 30 others

CompletedADvance DBS-f in Patients With Mild Probable Alzheimer's DiseaseThe primary objective of this feasibility study is to evaluate the safety of DBS-f in patients with mild Alzheimer's disease by assessing all device and/or therapy related adverse…NCT01608061·Phoenix, Arizona and 6 others

CompletedA Phase 3 Study Evaluating Safety and Effectiveness of Immune Globulin Intravenous (IGIV 10%) for the Treatment of Mild-to-Moderate Alzheimer´s DiseaseThe purpose of this study was to evaluate the efficacy and safety of 2 doses of Immune Globulin Intravenous (IGIV), 10% administered every 2 weeks as an intravenous (IV) infusion…NCT00818662·Birmingham, Alabama and 40 others

CompletedEffect of LY450139 on the Long Term Progression of Alzheimer's DiseaseAlzheimer's disease (AD) is a fatal degenerative disease of the brain for which there is no cure. AD causes brain cells to die.NCT00594568·Birmingham, Alabama and 147 others

PreviousPage 4 of 12Next

Other Conditions in Phoenix

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia